APA (7th ed.) Citation

Riabov, V., Xu, Q., Schmitt, N., Streuer, A., Ge, G., Bolanos, L., . . . Nowak, D. (2024). ASXL1 mutations are associated with a response to alvocidib and 5-azacytidine combination in myelodysplastic neoplasms. Haematologica, 109(5), . https://doi.org/10.3324/haematol.2023.282921

Chicago Style (17th ed.) Citation

Riabov, Vladimir, et al. "ASXL1 Mutations Are Associated with a Response to Alvocidib and 5-azacytidine Combination in Myelodysplastic Neoplasms." Haematologica 109, no. 5 (2024). https://doi.org/10.3324/haematol.2023.282921.

MLA (9th ed.) Citation

Riabov, Vladimir, et al. "ASXL1 Mutations Are Associated with a Response to Alvocidib and 5-azacytidine Combination in Myelodysplastic Neoplasms." Haematologica, vol. 109, no. 5, 2024, https://doi.org/10.3324/haematol.2023.282921.